Lachand A T, Martin-Mondières C
Eur Urol. 1979;5(2):117-9. doi: 10.1159/000473082.
By intradermal injection of 3 recall antigens, nonspecific secondary cell immunity was studied in 61 patients with prostatic carcinomas. Immune competence is lower in patients with metastatic disease. Skin tests have a short-term prognostical value.
通过皮内注射3种回忆抗原,对61例前列腺癌患者的非特异性继发性细胞免疫进行了研究。转移性疾病患者的免疫能力较低。皮肤试验具有短期预后价值。